In recent years, a tremendous amount of effort has been focused on better understanding the fundamentals of Alzheimer’s disease (AD) to facilitate early and accurate diagnosis and appropriately targeted therapeutic treatments. Alzheimer’s Disease: Targets for New Clinical, Diagnostic, and Therapeutic Strategies provides a detailed synopsis of the current state of the art of diagnostics and therapeutics and identifies emerging technologies and molecules that show promise in the management and treatment of AD.
With contributions from experts drawn from academia, clinical practice, and the biotechnology and pharmaceutical industries, the book explores:
Examining current hypotheses and suggesting possible new approaches to therapeutic clinical applications, this volume paves the way for a robust pipeline of therapeutics to combat not only AD, but a whole host of other neurodegenerative diseases.
The Amyloid β-Protein and Alzheimer’s Disease; David B. Teplow, Mingfeng Yang, Robin Roychaudhuri, Eric Pang, Tien-Phat Huynh, Mei-Sha Chen, and Shiela Beroukhim
Emerging Principles and Biomarkers in In Vitro Diagnostics for Alzheimer’s Disease; Renee D. Wegrzyn and Alan S. Rudolph
Imaging Biomarkers for Diagnosis, Prognosis, and Treatment of Alzheimer’s Disease; Daniel M. Skovronsky and Giora Z. Feuerstein
The Current Status of Alzheimer’s Disease Treatment: Why We Need Better Therapies and How We Will Develop Them; Krista L. Lanctôt, Ida Kircanski, Sarah A. Chau, and Nathan Herrmann
New Small Molecule Drug Discovery for Alzheimer’s Disease; Kangning Liu, Minhua Zhang, and Guhan Nagappan
Alzheimer’s Disease: Clinical Aspects; R. Scott Turner
Pathogenic Protein Strains as Diagnostic and Therapeutic Targets in Alzheimer’s Disease; Lary C. Walker, Rebecca F. Rosen, and Harry LeVine III
Traumatic Brain Injury in the Development of Alzheimer’s Disease: Risk Factors, Diagnosis, and Treatment Strategies; Mark P. Burns